X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
https://www.prnewswire.com/news-releases/fennec-pharmaceuticals-and-norgine-enter-into-exclusive-licensing-agreement-to-commercialize-pedmarqsi-in-europe-australia-and-new-zealand-302090953.html
https://www.globenewswire.com//news-release/2024/02/01/2821780/0/en/FDA-Issues-Reminder-of-Non-Substitution-of-PEDMARK-sodium-thiosulfate-injection-for-Pediatric-Patients-Receiving-Cisplatin.html
https://www.ema.europa.eu/en/documents/overview/pedmarqsi-epar-medicine-overview_en.pdf
https://www.biospace.com/article/fennec-pharmaceuticals-announces-european-commission-marketing-authorization-for-pedmarqsi-sodium-thiosulfate-to-reduce-the-risk-of-hearing-loss-in-pediatric-oncology-patients/
https://www.globenewswire.com/news-release/2023/06/06/2682568/0/en/Fennec-Pharmaceuticals-Announces-European-Commission-Marketing-Authorization-for-Pedmarqsi-sodium-thiosulfate-to-Reduce-the-Risk-of-Hearing-Loss-in-Pediatric-Oncology-Patients.html
https://www.ema.europa.eu/en/documents/overview/pedmarqsi-epar-medicine-overview_en.pdf
https://www.globenewswire.com/news-release/2023/03/31/2638604/0/en/Fennec-Pharmaceuticals-Receives-Positive-CHMP-Opinion-for-Pedmarqsi-sodium-thiosulfate-to-Reduce-the-Risk-of-Hearing-Loss-in-Pediatric-Oncology-Patients.html
https://www.onclive.com/view/fda-grants-orphan-drug-exclusivity-to-pedmark-for-prevention-of-platinum-induced-ototoxicity-in-pediatric-solid-tumors
https://www.globenewswire.com/news-release/2023/01/31/2598181/0/en/Fennec-Pharmaceuticals-Announces-PEDMARK-sodium-thiosulfate-injection-Receives-Orphan-Drug-Exclusivity-from-U-S-FDA.html
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-sodium-thiosulfate-intravenous-injection-9138.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-sodium-thiosulfate-1655270314.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-aprepitant-azilsartan-bupivacaine-cladribine-elrombopag-fosnetupitant-fostamatinib-ivacaftor-and-sodium-thiosulfate-1655270821.pdf
https://www.globenewswire.com/news-release/2022/01/31/2375549/0/en/Fennec-Pharmaceuticals-Announces-Management-Change.html
https://endpts.com/more-manufacturing-issues-fennec-preps-for-second-crl-for-potential-hearing-loss-drug/
https://www.fda.gov/ucm/groups/fdagov-public/@fdagov-afda-orgs/documents/document/ucm626326.pdf
Market Place
Share 
